O'Nesha Cochran, certified peer recovery mentor with Project IMPACT. (OHSU/Kristyna Wentz-Graff)

Tom Scanlan, Ph.D. (left) and Meredith D. Hartley, Ph.D. are researching a synthetic thyroid hormone that might possibly help stop the progression of the neurodegenerative disease adrenoleukodystrophy, or ALD. (OHSU/Kristyna Wentz-Graff)

Tom Scanlan, Ph.D. (left) and Meredith D. Hartley, Ph.D. look over data on March, 10, 2017, part of their research on a synthetic thyroid hormone that might possibly help stop the progression of the neurodegenerative disease adrenoleukodystrophy, or ALD. (OHSU/Kristyna Wentz-Graff)

Tom Scanlan, Ph.D. a professor of physiology and pharmacology in the OHSU School of Medicine, March 10, 2017. (OHSU/Kristyna Wentz-Graff)

Meredith D. Hartley, Ph.D., March 10, 2017. (OHSU/Kristyna Wentz-Graff)

Justin Cetas, M.D., an associate professor of neurological surgery in the OHSU School of Medicine. (OHSU/Fritz Liedtke)

Elizabeth Whispell stands near Niagara Falls during a vacation in July of last year. A friend had noticed a slight broadening of her face and hands, a possible sign of acromegaly, which prompted her to be treated at the Northwest Pituitary Center at OHSU in the fall of 2016. (OHSU)

Doernbecher Freestyle logo.

Doernbecher Freestyle patient-designer Andy Grass works with his Nike design team in 2016. (OHSU)

As part of the National Nurses Week events, research and and quality improvement measures by nurses at OHSU are highlighted in a poster contest. (OHSU/Kristyna Wentz-Graff)